Inactive Instrument

Antares

Equities

ANT

BE0003676872

Diversified Investment Services

Immo-Antares NV Reports Earnings Results for the Full Year Ended November 10, 2021

February 23, 2022 at 08:02 pm

Immo-Antares NV reported earnings results for the full year ended November 10, 2021. For the full year, the company reported sales was EUR 0.047693 million compared to EUR 1.39 million a year ago. Revenue was EUR 1.72 million compared to EUR 2.02 million a year ago.

Net income was EUR 0.822538 million compared to EUR 0.22725 million a year ago.

Latest news about Antares

Antares Pharma Posts Higher Q4 Adjusted Earnings, Revenue; Issues 2022 Revenue Guidance	22-03-03	MT
Earnings Flash (ATRS) ANTARES PHARMA Reports Q4 Revenue $48.7M, vs. Street Est of $47.2M	22-03-03	MT
Earnings Flash (ATRS) ANTARES PHARMA Posts Q4 EPS $0.02, vs. Street Est of $0.01	22-03-03	MT
North American Morning Briefing : Oil Prices Top -3-	22-03-03	DJ
Immo-Antares NV Reports Earnings Results for the Full Year Ended November 10, 2021	22-02-23	CI
Antares Vision Closes Acquisition Of US Software Firm ACSIS	22-02-18	MT
Antares Pharma's New Drug Application Resubmission for Testosterone Replacement Therapy Receives FDA Acceptance	22-02-03	MT
Antares Pharma Secures FDA Fast Track Designation for ATRS-1902 in Acute Adrenal Insufficiency	22-01-18	MT
Antares Gets FDA Fast-Track Designation for ATRS-1902 for Adrenal Crisis Rescue	22-01-18	DJ
Antares Pharma Says its Early-Stage Study of ATRS-1902 for Acute Adrenal Insufficiency Met its Primary Objective	22-01-11	MT
Assertio Therapeutics Acquires Otrexup from Antares Pharma for $44 Million	21-12-16	MT
Exclusive-Canada's CPP Investments seeks to sell insurance groups in strategy U-turn -sources	21-12-08	RE
Antares Pharma Q3 Earnings Steady as Revenue Rises; Narrows Full-Year Sales Guidance -- Stock Drops	21-11-04	MT
Earnings Flash (ATRS) ANTARES PHARMA Posts Q3 Revenue $48.2M, vs. Street Est of $47.9M	21-11-04	MT
Lipocine : Signs Deal with Antares Pharma for Commercialization of Tlando in the US; Shares Rise Pre-Bell	21-10-18	MT
Antares Pharma : Strikes Exclusive License Agreement For Oral Testosterone Replacement Therapy in US	21-10-18	MT
Antares Pharma : Starts Phase 1 Study of ATRS-1902 Drug for Acute Adrenal Insufficiency Treatment	21-09-30	MT
Antares Vision S p A : to Add Traceability to Russian Mineral Water Producer	21-09-28	MT
Antares Vision S p A : to Join FTSE Italia Mid Cap Index on Sept. 20	21-09-02	MT
Antares Pharma : Earnings Flash (ATRS) ANTARES PHARMA Reports Q2 Revenue $45M, vs. Street Est of $43.3M	21-08-05	MT
Antares Pharma : Earnings Flash (ATRS) ANTARES PHARMA Posts Q2 EPS $0.03, vs. Street Est of $0.02	21-08-05	MT
Antares Pharma : Gets US FDA OK to Start Trial of ATRS-1902 in Acute Adrenal Insufficiency	21-07-22	MT
Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at Antares Pharma	21-07-09	MT
Antares Pharma : ' Swiss Partner Idorsia Kicks Off Late-Stage Study for Selatogrel in Heart Attack Cases	21-06-28	MT
Idorsia : to trial self-injection drug for heart attack victims	21-06-28	RE

Chart Antares

Duration

Period

More charts

Company Profile

Antares is a real estate certificate issued by the company Immo-Antares. The activity of the company Immo-Antares consists in issuing certificates that gives the right to a quota of the distributions and determined property deals income. Real estate certificates are mainly offered to investors through a bid and are listed on the Brussels Euronext Regulated Market. Some are offered through a private offer. Immo-Antares issues real estate certificates that are admitted to trading on the Brussels Euronext Regulated Market, being specified that the shares constituting the capital of the company Le Patrimoine Immobilier are neither offered to the public nor, a fortiori, admitted to trading on a regulated market.

Sector

Diversified Investment Services

More about the company

Sector Diversified Investment Services

	1st Jan change	Capi.
MACQUARIE GROUP LIMITED	+5.70%	46.57B
EQUITABLE HOLDINGS, INC.	+21.59%	13.25B
SBI HOLDINGS, INC.	+26.26%	7.58B
VOYA FINANCIAL, INC.	+1.88%	7.53B
INVESTEC GROUP	+0.14%	6.28B
FIRST CAPITAL SECURITIES CO., LTD.	-2.75%	3.3B
AMP LIMITED	+17.74%	1.94B
AJ BELL PLC	+15.18%	1.89B
PT SARATOGA INVESTAMA SEDAYA TBK	-7.01%	1.31B

Diversified Investment Services